|
GB1120945A
(en)
|
1964-08-11 |
1968-07-24 |
Fisons Pharmaceuticals Ltd |
Applicator in combination with a pressurised aerosol dispensing container
|
|
EP0397834B1
(en)
|
1988-10-28 |
2000-02-02 |
Genentech, Inc. |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
ES2078518T3
(es)
|
1990-04-05 |
1995-12-16 |
Roberto Crea |
Mutagenesis por desplazamiento completo.
|
|
AU665025B2
(en)
|
1991-09-23 |
1995-12-14 |
Cambridge Antibody Technology Limited |
Production of chimeric antibodies - a combinatorial approach
|
|
DE69334095T2
(de)
|
1992-07-17 |
2007-04-12 |
Dana-Farber Cancer Institute, Boston |
Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
CA2164088C
(en)
|
1993-06-07 |
2005-06-14 |
Gary J. Nabel |
Plasmids suitable for gene therapy
|
|
EP0702721B1
(en)
|
1993-06-09 |
2001-01-03 |
Unilever N.V. |
Process for producing fusion proteins comprising scfv fragments by a transformed mould
|
|
US6091639A
(en)
|
1993-08-27 |
2000-07-18 |
Kabushiki Kaisha Toshiba |
Non-volatile semiconductor memory device and data programming method
|
|
KR960705209A
(ko)
|
1993-09-10 |
1996-10-09 |
잭 엠. 그랜노위츠 |
녹색 형광 단백의 용도
|
|
WO1995021191A1
(en)
|
1994-02-04 |
1995-08-10 |
William Ward |
Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
|
|
WO1995022618A1
(en)
|
1994-02-22 |
1995-08-24 |
Dana-Farber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US5693492A
(en)
|
1995-05-05 |
1997-12-02 |
Merck & Co., Inc. |
DNA encoding glutamate gated chloride channels
|
|
US5811524A
(en)
*
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
CA2225460A1
(en)
|
1995-06-23 |
1997-01-09 |
Winston Campbell Patterson |
Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
|
|
CA2232727C
(en)
|
1995-09-22 |
2002-03-26 |
Novo Nordisk A/S |
Novel variants of green fluorescent protein, gfp
|
|
US6027881A
(en)
|
1996-05-08 |
2000-02-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
|
|
US6020182A
(en)
*
|
1996-07-12 |
2000-02-01 |
Connaught Laboratories Limited |
Subunit respiratory syncytial virus vaccine preparation
|
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
|
CA2270288A1
(en)
*
|
1996-11-01 |
1998-05-14 |
Smithkline Beecham Corporation |
Human monoclonal antibodies
|
|
WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
|
AU7298398A
(en)
|
1996-11-19 |
1998-06-10 |
Sangstat Medical Corporation |
Enhanced effects for hapten conjugated therapeutics
|
|
US7122636B1
(en)
|
1997-02-21 |
2006-10-17 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and uses of same
|
|
US6329516B1
(en)
|
1997-04-28 |
2001-12-11 |
Fmc Corporation |
Lepidopteran GABA-gated chloride channels
|
|
FR2766826B1
(fr)
|
1997-08-04 |
2001-05-18 |
Pasteur Institut |
Vecteurs derives d'anticorps pour le transfert de substances dans les cellules
|
|
AU3295299A
(en)
|
1998-02-19 |
1999-09-06 |
Xcyte Therapies, Inc. |
Compositions and methods for regulating lymphocyte activation
|
|
GB9824632D0
(en)
|
1998-11-10 |
1999-01-06 |
Celltech Therapeutics Ltd |
Biological compounds
|
|
CA2361678A1
(en)
|
1999-02-05 |
2000-08-10 |
Rijksuniversiteit Leiden |
Method of modulating metabolite biosynthesis in recombinant cells
|
|
CN1252264C
(zh)
|
1999-04-22 |
2006-04-19 |
荷兰联合利华有限公司 |
利用单价抗原－结合蛋白抑制病毒感染
|
|
AR030019A1
(es)
*
|
1999-05-18 |
2003-08-13 |
Smithkline Beecham Corp |
Anticuerpos monoclonales humanos y fragmentos funcionales del mismo, un procedimiento para su produccion, composiciones farmaceuticas que los comprenden, una molecula aislada de acido nucleico, un plasmido recombinante, una celula hospedante y el uso de dichos anticuerpos para la manufactura de un m
|
|
EP1198572A2
(en)
|
1999-08-02 |
2002-04-24 |
Keygene N.V. |
Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants
|
|
GB9922124D0
(en)
|
1999-09-17 |
1999-11-17 |
Pfizer Ltd |
Phosphodiesterase enzymes
|
|
US6849425B1
(en)
|
1999-10-14 |
2005-02-01 |
Ixsys, Inc. |
Methods of optimizing antibody variable region binding affinity
|
|
DE19955408A1
(de)
|
1999-11-18 |
2001-05-23 |
Bayer Ag |
GABA-B-Rezeptoren
|
|
EP2180054A1
(en)
|
1999-12-24 |
2010-04-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US6741957B1
(en)
|
2000-07-21 |
2004-05-25 |
Daimlerchrysler Corporation |
Analytical tire model for vehicle durability and ride comfort analysis
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
US7054297B1
(en)
|
2000-12-28 |
2006-05-30 |
Cisco Technology, Inc. |
Distribution of packets to high data rate communications devices using multicast protocols
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
AU2002241922B2
(en)
|
2001-01-17 |
2007-10-25 |
Aptevo Research And Development Llc |
Binding domain-immunoglobulin fusion proteins
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
DK1399484T3
(da)
|
2001-06-28 |
2010-11-08 |
Domantis Ltd |
Dobbelt-specifik ligand og anvendelse af denne
|
|
US20060073141A1
(en)
|
2001-06-28 |
2006-04-06 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
AU2002355477B2
(en)
|
2001-08-03 |
2008-09-25 |
Medical Research Council |
Method of identifying a consensus sequence for intracellular antibodies
|
|
FR2829940A1
(fr)
|
2001-09-27 |
2003-03-28 |
Synt Em |
Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central
|
|
KR100599789B1
(ko)
|
2001-12-03 |
2006-07-12 |
삼성에스디아이 주식회사 |
방열효율이 향상된 플라즈마 디스플레이 장치 및 그 제조방법
|
|
EP1456410A2
(en)
|
2001-12-11 |
2004-09-15 |
AlgoNomics N.V. |
Method for displaying loops from immunoglobulin domains in different contexts
|
|
KR20040076869A
(ko)
|
2001-12-18 |
2004-09-03 |
인노제네틱스 엔. 브이. |
진단적 및 치료적 용도를 위한 정제된 ｃ형 간염 바이러스외피 단백질
|
|
EP1532175B1
(en)
|
2002-03-22 |
2012-10-17 |
Aprogen, Inc. |
Humanized antibody and process for preparing the same
|
|
US7132100B2
(en)
*
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
ES2263984T3
(es)
|
2002-06-28 |
2006-12-16 |
Domantis Limited |
Ligandos doble-especificos con una vida media serica aumentada.
|
|
US7004940B2
(en)
|
2002-10-10 |
2006-02-28 |
Ethicon, Inc. |
Devices for performing thermal ablation having movable ultrasound transducers
|
|
US7521543B2
(en)
|
2002-10-23 |
2009-04-21 |
Ludwig Institute For Cancer Research |
A34 and A33-like 3 DNA, proteins, antibodies thereto and methods of treatment using same
|
|
WO2010081856A1
(en)
|
2009-01-14 |
2010-07-22 |
Ablynx Nv |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
WO2004041867A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
|
|
CA2505316C
(en)
|
2002-11-08 |
2014-08-05 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
GB0230203D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
|
WO2004060965A2
(en)
|
2002-12-31 |
2004-07-22 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
EP1587838B1
(en)
|
2003-01-10 |
2015-04-15 |
Ablynx N.V. |
Therapeutic polypeptides, homologues thereof, fragments thereof and their use in modulating platelet-mediated aggregation
|
|
ES2408582T3
(es)
|
2003-05-30 |
2013-06-21 |
Merus B.V. |
Biblioteca de Fab para la preparación de una mezcla de anticuerpos
|
|
US7070786B2
(en)
|
2003-06-06 |
2006-07-04 |
Centocor, Inc. |
RSV proteins, antibodies, compositions, methods and uses
|
|
AU2004254352A1
(en)
|
2003-06-27 |
2005-01-13 |
Roberto Crea |
Look-through mutagenesis
|
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
|
WO2005001690A2
(de)
|
2003-06-30 |
2005-01-06 |
Siemens Aktiengesellschaft |
Verfahren zur überwachung des programmlaufs in einem mikro-computer
|
|
AU2003264053A1
(en)
|
2003-08-12 |
2005-03-10 |
William M. Yarbrough |
Treatment for acne vulgaris and method of use
|
|
EP1512696A1
(en)
|
2003-08-14 |
2005-03-09 |
Diatos |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
DK1737971T3
(da)
|
2004-01-20 |
2017-11-13 |
Merus Nv |
Blandinger af bindingsproteiner
|
|
EP1720908A2
(en)
*
|
2004-02-17 |
2006-11-15 |
Absalus, Inc. |
Super-humanized antibodies against respiratory syncytial virus
|
|
US7207410B2
(en)
|
2004-04-29 |
2007-04-24 |
Daimlerchrysler Corporation |
Apparatus and method for enhanced impact sensing
|
|
KR101699142B1
(ko)
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
|
JP4939410B2
(ja)
|
2004-07-06 |
2012-05-23 |
バイオレン，インク． |
強化された特性を持つ変性ポリペプチドを発生させるためのルックスルー変異誘発
|
|
US7180370B2
(en)
|
2004-09-01 |
2007-02-20 |
Micron Technology, Inc. |
CMOS amplifiers with frequency compensating capacitors
|
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
|
WO2006034292A2
(en)
|
2004-09-21 |
2006-03-30 |
Medimmune, Inc. |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
|
WO2006040153A2
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
|
TW200636064A
(en)
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
AU2005302453A1
(en)
|
2004-10-29 |
2006-05-11 |
Medimmune, Llc |
Methods of preventing and treating RSV infections and related conditions
|
|
CA2588892A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Dormantis Limited |
Anti-il-1r1 single domain antibodies and therapeutic uses
|
|
EP1874824A4
(en)
*
|
2005-04-06 |
2009-12-30 |
Ibc Pharmaceuticals Inc |
METHODS OF GENERATING STABLE COMPOUND RELATED COMPLEXES OF HOMODIMERS, HOMOTRATEERS OR DIMER SIZES AND USES THEREOF
|
|
CA2603940A1
(en)
|
2005-04-08 |
2006-10-19 |
Nancy Ulbrandt |
Antibodies against mammalian metapneumovirus
|
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
CN101646689A
(zh)
|
2006-09-08 |
2010-02-10 |
埃博灵克斯股份有限公司 |
具有长半衰期的血清清蛋白结合蛋白
|
|
US20100034194A1
(en)
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
|
WO2008043821A1
(en)
|
2006-10-11 |
2008-04-17 |
Ablynx N. V. |
Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
|
|
US20100129354A1
(en)
|
2006-10-27 |
2010-05-27 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
CA2671581A1
(en)
|
2006-12-05 |
2008-06-12 |
Ablynx N.V. |
Peptides capable of binding to serum proteins
|
|
WO2008077945A2
(en)
|
2006-12-22 |
2008-07-03 |
Ablynx N.V. |
Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies
|
|
EP2173772A2
(en)
|
2007-07-03 |
2010-04-14 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating cdr and/or fr positions
|
|
EP2220120A2
(en)
|
2007-11-27 |
2010-08-25 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
EP2096121A1
(en)
|
2008-02-29 |
2009-09-02 |
Institut Pasteur Of Shanghai |
Antiviral peptides comprising lipid attachment signals and methods of use
|
|
AU2009254501B2
(en)
|
2008-06-05 |
2014-07-31 |
Ablynx N.V. |
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
|
|
ES2551854T3
(es)
|
2009-04-30 |
2015-11-24 |
Ablynx N.V. |
Procedimiento para la producción de anticuerpos de dominio
|
|
ES2643034T3
(es)
|
2009-06-05 |
2017-11-21 |
Ablynx N.V. |
Construcciones de Nanobody contra el virus respiratorio sincicial humano (VRSH) trivalentes para la prevención y/o el tratamiento de infecciones de las vías respiratorias
|
|
WO2011064382A1
(en)
|
2009-11-30 |
2011-06-03 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|